This chapter provides an overview of the new pharmacological strategies in
Parkinson's disease (PD). Levodopa (LD) is considered the mainstay of treatment
of Parkinson's disease (PD). However, LD has not been shown to slow the
progression of the disease, and PD patients face major shortcomings in the
chronic phase of the disease. Fluctuations and levodopa-induced dyskinesia (LID)
are the major com... hiện toàn bộ